An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathway
Open Access
- 26 September 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (46) , 75539-75550
Abstract
An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathway An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathwayKeywords
This publication has 36 references indexed in Scilit:
- Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 SignalingCancer Cell, 2016
- Downregulation of STAT3 phosphorylation enhances tumoricidal effect of IL-15-activated dendritic cell against doxorubicin-resistant lymphoma and leukemia via TNF-αThe International Journal of Biochemistry & Cell Biology, 2015
- SC06, a novel small molecule compound, displays preclinical activity against multiple myeloma by disrupting the mTOR signaling pathwayScientific Reports, 2015
- Discovery of selective phosphatidylinositol 3-kinase inhibitors to treat hematological malignanciesDrug Discovery Today, 2015
- Phase I study of OPB‐51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignanciesCancer Science, 2015
- The Antiparasitic Clioquinol Induces Apoptosis in Leukemia and Myeloma Cells by Inhibiting Histone Deacetylase ActivityJournal of Biological Chemistry, 2013
- Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenograftsProceedings of the National Academy of Sciences, 2012
- Inhibiting aberrant Stat3 function with molecular therapeuticsAnti-Cancer Drugs, 2011
- Cyproheptadine displays preclinical activity in myeloma and leukemiaBlood, 2008
- Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesisOncogene, 2004